130 related articles for article (PubMed ID: 1438799)
1. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas.
Dummer R; Röger J; Vogt T; Becker J; Hefner H; Sindermann H; Burg G
Prog Exp Tumor Res; 1992; 34():160-9. PubMed ID: 1438799
[No Abstract] [Full Text] [Related]
2. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
Unger C; Sindermann H; Peukert M; Hilgard P; Engel J; Eibl H
Prog Exp Tumor Res; 1992; 34():153-9. PubMed ID: 1438798
[No Abstract] [Full Text] [Related]
3. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study.
Dummer R; Krasovec M; Röger J; Sindermann H; Burg G
J Am Acad Dermatol; 1993 Dec; 29(6):963-70. PubMed ID: 8245262
[TBL] [Abstract][Full Text] [Related]
4. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
Unger C; Peukert M; Sindermann H; Hilgard P; Nagel G; Eibl H
Cancer Treat Rev; 1990 Sep; 17(2-3):243-6. PubMed ID: 2272039
[TBL] [Abstract][Full Text] [Related]
5. [Multiple cutaneous plasmocytoma treated with topical applications of miltefosine].
Viseux V; Schoenlaub P; Danhier S; Vilque JP; Plantin P
Ann Dermatol Venereol; 2004 Feb; 131(2):204-5. PubMed ID: 15026752
[No Abstract] [Full Text] [Related]
6. [Treatment of cutaneous metastases of a squamous cell carcinoma of the leg with topical miltefosine].
Mahieu-Renard L; Richard MA; Dales JP; Buscaylet S; Lagrassa S; Grob JJ
Ann Dermatol Venereol; 2005 Apr; 132(4):346-8. PubMed ID: 15886562
[TBL] [Abstract][Full Text] [Related]
7. Hexadecylphosphocholine (D 18506) in the topical treatment of skin metastases: a phase-I trial.
Unger C; Eibl H; Breiser A; von Heyden HW; Engel J; Hilgard P; Sindermann H; Peukert M; Nagel GA
Onkologie; 1988 Dec; 11(6):295-6. PubMed ID: 3071766
[No Abstract] [Full Text] [Related]
8. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.
Leonard R; Hardy J; van Tienhoven G; Houston S; Simmonds P; David M; Mansi J
J Clin Oncol; 2001 Nov; 19(21):4150-9. PubMed ID: 11689583
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of miltefosine in patients with cutaneous T-cell lymphoma.
Dumontet C; Thomas L; Bérard F; Gimonet JF; Coiffier B
Bull Cancer; 2006 Nov; 93(11):E115-8. PubMed ID: 17145574
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer.
Terwogt JM; Mandjes IA; Sindermann H; Beijnen JH; ten Bokkel Huinink WW
Br J Cancer; 1999 Mar; 79(7-8):1158-61. PubMed ID: 10098751
[TBL] [Abstract][Full Text] [Related]
11. Miltefosine: new preparation. Solution for cutaneous application.
Prescrire Int; 1998 Feb; 7(33):5-6. PubMed ID: 10183390
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients.
Smorenburg CH; Seynaeve C; Bontenbal M; Planting AS; Sindermann H; Verweij J
Anticancer Drugs; 2000 Nov; 11(10):825-8. PubMed ID: 11142690
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer.
Planting AS; Stoter G; Verweij J
Eur J Cancer; 1993; 29A(4):518-9. PubMed ID: 8435202
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy for advanced cutaneous T-cell lymphomas.
Raafat J; Oster MW; Lo Gerfo P; Edelson RL
Cancer Treat Rep; 1980; 64(12):1371-4. PubMed ID: 6162558
[TBL] [Abstract][Full Text] [Related]
16. Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex).
Ragnarsson-Olding B; Djureen-Mårtensson E; Månsson-Brahme E; Hansson J
Acta Oncol; 2005; 44(7):773-7. PubMed ID: 16227173
[No Abstract] [Full Text] [Related]
17. A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours.
Verweij J; Planting A; van der Burg M; Stoter G
J Cancer Res Clin Oncol; 1992; 118(8):606-8. PubMed ID: 1325463
[TBL] [Abstract][Full Text] [Related]
18. Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma.
Clive S; Gardiner J; Leonard RC
Cancer Chemother Pharmacol; 1999; 44 Suppl():S29-30. PubMed ID: 10602908
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod.
Stavrakoglou A; Brown VL; Coutts I
Br J Dermatol; 2007 Sep; 157(3):620-2. PubMed ID: 17553050
[No Abstract] [Full Text] [Related]
20. Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases of the skin; the 5-year Norwich experience.
Moncrieff M; Fadhil M; Garioch J
Br J Dermatol; 2016 May; 174(5):1141-2. PubMed ID: 26598951
[No Abstract] [Full Text] [Related]
[Next] [New Search]
